Biotech Values

[mcbio]

Seems a mighty expensive way to discover whether CRP is simply a biomarker reflecting existing inflammation (which is my mostly uninformed guess) or actually a bad actor in and of itself.

But if it's the latter they will have first-mover advantage in the clinic.